BSE filing, NSE: KIRANVYPAR. Summary written from the filing by ALFA Finder's alert engine.
Kiran Vyapar Ltd: key numbers
- Share price
- ₹199.80
- Market cap
- ₹545.1 Cr
- Revenue (annual)
- ₹106.7 Cr
- Net profit (annual)
- ₹1.02 Cr
- P/E (TTM)
- 79.0×Sector 33.6×
- Promoter holding
- 74.96%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kiran Vyapar Ltd
All →Kiran Vyapar Board Meeting Date
Kiran Vyapar will hold a board meeting on 2 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window is closed from 1 October and reopens on 5 November 2026.
Kiran Vyapar Promoter Buying (Off-Market)
Kiran Vyapar Ltd reported an inter-se transfer of 92,38,132 shares within the promoter group following the merger of Placid Limited into Maharaja Shree Umaid Mills Limited.
Kiran Vyapar Acquisition Worth ₹11.86 Cr
Kiran Vyapar Limited acquired a 0.68% stake in Greshma Finvest Private Limited for a total consideration not exceeding ₹11.86 Crore.
- Value
- ₹11.86 Cr
Kiran Vyapar Annual General Meeting
Kiran Vyapar Limited held its 30th Annual General Meeting on September 26, 2026. Members transacted routine business, including adopting financial statements and declaring a dividend.
Kiran Vyapar Annual General Meeting
Kiran Vyapar Limited issued notice for its 30th Annual General Meeting to be held on 26th September 2026, including agendas for dividend and material related party transactions.
Kiran Vyapar Other Announcement
Kiran Vyapar Limited has announced book closure from September 20, 2026, to September 26, 2026, to determine shareholders eligible for dividend payment.
Other acquisition announcements
All →Laurus Labs Acquisition Worth ₹32.5 Cr
Laurus Labs approved acquiring 52% of SI & C Resins for Rs. 32.50 Crore. The acquisition makes SI&C a subsidiary for peptide resin manufacturing.
- Value
- ₹32.50 Cr
Laurus Labs Acquisition Worth ₹35.63 Cr
Laurus Labs approved buying 60% of Canada-based CRO Galenvs Sciences for USD 3.75 million (₹35.63 Cr). The deal adds an oligonucleotide R&D arm and North American presence.
- Value
- ₹35.63 Cr
Raghav Productivity Enhancers Acquisition
RPEL acquires 80% of RPEL TRLK Silicatech Private Limited for a nominal cash subscription. The target manufactures silica ramming mass and other refractories in India.
Container Corporation of India Acquisition Worth ₹485.9 Cr
CONCOR placed an order with Braithwaite & Co for 24 rakes of BLSS wagons. The deal, including GST, values at Rs.485.93 Crores.
- Value
- ₹485.9 Cr
- Execution
- Delivery by 20.06.2028
- BLSS wagons (fleet)
- 24.0 rakes
Embassy Developments Acquisition Worth ₹32.65 Cr
Embassy Developments signed an SPA to acquire 50% of Embassy Columbia Pacific ASL for ₹32.65 Crore. The JV will become wholly owned upon closing by December 2026.
- Value
- ₹32.65 Cr
- Execution
- Within the current quarter ending on December 31, 2026
MosChip Technologies Acquisition Worth ₹266.7 Cr
MosChip will acquire Vayavya Labs for Rs.266.71 Crore in cash and shares. Completion awaits RBI and exchange approvals and shareholder approval of a preferential issue.
- Value
- ₹266.7 Cr
- Execution
- Within 15 days of the later of receipt of all requisite approvals or shareholder approval of the preferential issue to VLPL sellers